Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent versus continuous N-acetylcysteine infusion in ICU patients with sepsis
IRCT201512118384N6Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of acetylcysteine in sepsis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Oxidative stress level and Total antioxidant capacity. Started Nov 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
sepsis
Beyond the preview
Go deeper on IRCT201512118384N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201512118384N6.